Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluconazole 150mg - capsule - 150 mg - active: fluconazole 150mg excipient: ammonia solution butyl alcohol colloidal silicon dioxide ethanol gelatin   iron oxide black isopropyl alcohol lactose monohydrate magnesium stearate maize starch patent blue v   potassium hydroxide propylene glycol purified water   shellac sodium laurilsulfate titanium dioxide   water - ozole 150 mg capsule, given orally, is indicated for vaginal candidiasis.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - trastuzumab 150mg (excludes 4% overage);  ;  ;   - powder for infusion concentrate - 150 mg - active: trastuzumab 150mg (excludes 4% overage)       excipient: histidine histidine hydrochloride monohydrate polysorbate 20 trehalose - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: a) as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or b) in combination with taxanes for the treatment of those patients who have not received chemotherapy for their metastatic disease; or c) in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

regional health ltd - iopamidol 30.62%{relative} equivalent to 150 mg/ml iodine;   - solution for injection - 150 mg/ml - active: iopamidol 30.62%{relative} equivalent to 150 mg/ml iodine   excipient: hydrochloric acid sodium calcium edetate, hydrate trometamol

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg; zidovudine 300mg - film coated tablet - active: lamivudine 150mg zidovudine 300mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4+ count = < 500 cells/mm³).

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg;  ;   - film coated tablet - 150 mg - active: lamivudine 150mg     excipient: magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - lamuvidine in combination with other anti-retroviral agents is indicated for the treatment of hiv-infected adults and children.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - rifabutin 150mg - capsule - 150 mg - active: rifabutin 150mg - mycobutin is indicated for infections caused by mycobacteria, such as m. tuberculosis, m. avium intracellulare complex (mac) and other atypical mycobacteria. in infections caused by mac and other atypical mycobacteria such as m. xenopi, mycobutin has been shown to be effective for the treatment of both disseminated and localised disease, also in immunocompromised hiv positive patients. mycobutin is also indicated for the prophylaxis of m. avium intracellulare complex (mac) infections in immunodepressed patients with cd4 counts lower than or equal to 100/ml. in the treatment of tubercular disease, mycobutin has been shown to be effective for the treatment of patients with chronic pulmonary tuberculosis, even if caused by multidrug-resistant m. tuberculosis strains. in accordance with the commonly accepted criteria for the treatment of mycobacterial infections, mycobutin therapy should always be given in combination with other antimycobacterial drugs not belonging to the family of rifamycins.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg;  ;   - capsule - 150 mg - active: dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 0 (tt70-14-2-4) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 162.52mg equivalent to darunavir 150 mg - film coated tablet - 150 mg - active: darunavir ethanolate 162.52mg equivalent to darunavir 150 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry white 85f18422 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

actavis new zealand limited - ranitidine hydrochloride 168mg equivalent to 150 mg ranitidine - film coated tablet - 150 mg - active: ranitidine hydrochloride 168mg equivalent to 150 mg ranitidine excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry white oy-ls-28908 purified water